دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Clinical Images: Injury to the articular cartilage affects growth of subchondral bone in a patient with osteoarthritis
Masaki Hatano,Izuru Kitajima,Seizo Yamamoto,Masaki Nakamura,Kazuya Isawa,Tatsuya Suwabe,Junichi Hoshino,Naoki Sawa,Yoshifumi Ubara
doi : 10.1002/acr2.11333
Volume 3, Issue 12 p. 817-819
Performance of Cytokine Storm Syndrome Scoring Systems in Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children
Daniel D. Reiff,Randy Q. Cron
doi : 10.1002/acr2.11331
Volume 3, Issue 12 p. 820-826
The objective of this study is to evaluate pediatric patients using existing macrophage activation syndrome (MAS) and hemophagocytic lymphohistiocytosis (HLH) scoring systems to determine how these systems identify patients with cytokine storm syndrome (CSS) in the setting of a multisystem inflammatory syndrome in children (MIS-C) and active coronavirus disease 2019 (COVID-19) infection.
Journal Club: Efficacy and Safety of Voclosporin Versus Placebo for Lupus Nephritis (AURORA 1): A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Phase 3 Trial
Jose Rubio,Vasileios Kyttaris
doi : 10.1002/acr2.11338
Volume 3, Issue 12 p. 827-831
Voclosporin, a novel calcineurin inhibitor approved for the treatment of adults with lupus nephritis (LN), improved complete renal response rates in patients with LN in a phase 2 trial. This study aimed to evaluate the efficacy and safety of voclosporin for the treatment of LN.
Incidence of Disease Flare After BNT162b2 Coronavirus Disease 2019 Vaccination in Patients With Rheumatoid Arthritis in Remission
Riccardo Bixio,Davide Bertelle,Marco Masia,Francesca Pistillo,Antonio Carletto,Maurizio Rossini
doi : 10.1002/acr2.11336
Volume 3, Issue 12 p. 832-833
Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic
Claire Cook,Huel Cox,Xiaoqing Fu,Yuqing Zhang,John H. Stone,Hyon K. Choi,Zachary S. Wallace
doi : 10.1002/acr2.11340
Volume 3, Issue 12 p. 834-841
To investigate the perceived risk of coronavirus disease 2019 (COVID-19) infection and outcomes as well as shielding practices among patients with rheumatoid arthritis (RA) during the COVID-19 pandemic.
Patient Empowerment and Associations with Disease Activity and Pain-Related and Lifestyle Factors in Patients With Rheumatoid Arthritis
Ingrid Larsson,Ann Bremander,Maria Andersson
doi : 10.1002/acr2.11341
Volume 3, Issue 12 p. 842-849
Empowerment is important to patients with rheumatoid arthritis (RA) because most care is in the form of self-management. The aim was to study levels of empowerment and associated variables in patients with RA and to investigate longitudinal clinical data in patients with low and high empowerment.
Hip Range of Motion and Strength Predict 12-Month Physical Function Outcomes in Older Adults With Chronic Low Back Pain: The Delaware Spine Studies
Peter C. Coyle,Patrick J. Knox,Ryan T. Pohlig,Jenifer M. Pugliese,J. Megan Sions,Gregory E. Hicks
doi : 10.1002/acr2.11342
Volume 3, Issue 12 p. 850-859
The objective of this study was to investigate whether poor hip range of motion (ROM) and strength predict 12-month physical function decline among older adults with chronic low back pain (LBP) and whether hip osteoarthritis modifies those relationships.
Effect of Training on Patient Self-Assessment of Joint Counts in Rheumatoid Arthritis: A Systematic Review
Keith Tam,Glen S. Hazlewood,Claire E. H. Barber
doi : 10.1002/acr2.11344
Volume 3, Issue 12 p. 860-869
Patient self-assessed joint counts, if accurate and reliable, could potentially serve as a useful clinical assessment tool in rheumatoid arthritis (RA). This systematic review examines the effect of patient training on the inter-rater reliability of joint counts between patients and clinicians.
Importance of Shared Treatment Goal Discussions in Rheumatoid Arthritis—A Cross-Sectional Survey: Patients Report Providers Seldom Discuss Treatment Goals and Outcomes Improve When Goals Are Discussed
Kelly D. O’Neill,Kathryne E. Marks,Pamela S. Sinicrope,Cynthia S. Crowson,Dana Symons,Elena Myasoedova,John M. Davis III
doi : 10.1002/acr2.11335
Volume 3, Issue 12 p. 870-878
Treat-to-target (T2T) and shared decision-making are valued features of current guidelines for rheumatoid arthritis (RA) management. Although T2T has demonstrated value for improving RA outcomes, implementation remains inconsistent and lacks standardization and procedures for including patient input. We sought to better understand the impact of shared decisions on T2T and how treatment goal discussions between patients and providers impact RA treatment improvement and satisfaction.
Real-World Treatment Patterns and Healthcare Costs in Patients with Psoriatic Arthritis Treated with Ixekizumab: A Retrospective Study
Mwangi J. Murage,Nicole Princic,Julie Park,William Malatestinic,Baojin Zhu,Bilal Atiya,Scott A. Kern,Keri B. Stenger,Aubrey Trevelin Sprabery,Alexis Ogdie
doi : 10.1002/acr2.11347
Volume 3, Issue 12 p. 879-887
To describe adherence, persistence, discontinuation, restarting, switching, dosing, and health care costs among patients with psoriatic arthritis (PsA) treated with ixekizumab (IXE).
Clinical Image: In vivo urate spherulites in a patient with gout
Ian Pirker,Madalina Nussberger,Johannes von Kempis
doi : 10.1002/acr2.11350
Volume 3, Issue 12 p. 888-888
Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis
Kaarina Kowalec,Heather Carney,Mitulkumar Patel,Carol Hitchon,James M. Bolton,Scott B. Patten,Lesley A. Graff,Charles N. Bernstein,Christine Peschken,Ruth Ann Marrie,for the Canadian Institutes of Health Research Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease
doi : 10.1002/acr2.11339
Volume 3, Issue 12 p. 889-896
In this study, we aimed to determine the lifetime prevalence of substance use disorder (SUD) in a Canadian rheumatoid arthritis (RA) cohort and factors associated with SUD in RA.
